Følg Karo Pharma

Tags

Forkjølelse

Tag / Weifa

Oppfriskende nyhet fra Weifa: Nazamér Mentol
Invitation to presentation of Weifa's Q4 2016 results

Invitation to presentation of Weifa's Q4 2016 results

Pressemeldinger   •   feb 10, 2017 10:05 CET

Norway's leading consumer health company, will release its fourth quarter and full-year 2016 results on Thursday 16 February 2017.

New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

New license agreement with AFT Pharmaceuticals for Nordic rights to groundbreaking product line within Pain Management

Pressemeldinger   •   jan 12, 2017 10:20 CET

Weifa has in-licensed a patented fixed-combination product line within pain management from AFT Pharmaceuticals (“AFT”) in New Zealand. The agreement gives rights to commercialize the products in the entire Nordic region (Norway, Sweden, Denmark, Finland and Iceland).

Invitation to presentation of Weifa's Q3 2016 results, Tuesday 25 October

Invitation to presentation of Weifa's Q3 2016 results, Tuesday 25 October

Pressemeldinger   •   okt 18, 2016 14:10 CEST

Norway's leading consumer health company, will release its third quarter 2016 results on Tuesday 25 October 2016.

Invitation to presentation of Weifa's Q2 2016 results

Invitation to presentation of Weifa's Q2 2016 results

Pressemeldinger   •   aug 18, 2016 09:40 CEST

Norway's leading consumer health company, will release its second quarter 2016 results on Thursday 25 August 2016.

Weifa ASA to launch  a new medicinal product for  insomnia in Norway

Weifa ASA to launch a new medicinal product for insomnia in Norway

Pressemeldinger   •   aug 10, 2016 14:58 CEST

Weifa ASA is pleased to announce the launch of Zonat® tablets, which is indicated for short-term symptomatic treatment of occasional insomnia in adults over 18 years old. Zonat® contains the antihistamine doxylamine, which is well established as a non-prescription (OTC) product for occasional insomnia in several European countries. In Norway Zonat® will require medical prescription.

Distribution agreement in Finland for unique pain products

Distribution agreement in Finland for unique pain products

Pressemeldinger   •   jun 06, 2016 13:30 CEST

Weifa has signed a 5-year distribution agreement with the Fysioline Group (Finland). The agreement covers several of Weifa’s most recently launched products within the pain category, and can be extended to include additional products.

Invitasjon til kvartalspresentasjon - Q1 2016

Invitasjon til kvartalspresentasjon - Q1 2016

Pressemeldinger   •   apr 20, 2016 10:00 CEST

Weifa ASA presenterer tallene for første kvartal 2016, tirsdag 26.april.

Pyricare - en steril saltvannspray

Pyricare - en steril saltvannspray

Pressemeldinger   •   feb 19, 2016 08:05 CET

​Pyricare er en nytt produkt fra Weifa innenfor sårbehandling. Pyricare steril saltvannspray til skyll og rens av akutte og kroniske sår. Små kuttsår og skrubbsår gror vanligvis uten behandling, men rengjøring av såret er viktig for å forebygge infeksjoner. Bakterier kan lett trenge inn i et åpent sår og forårsake infeksjon.